Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitors

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F10%3A00300132" target="_blank" >RIV/00216208:11140/10:00300132 - isvavai.cz</a>

Alternative codes found

RIV/00669806:_____/10:00300761 RIV/26475821:_____/10:#0000062

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitors

Original language description

Concurrent presence of EGFR and KRAS mutations in non-small-cell lung cancer (NSCLC) is relatively rare. Five case reports of multiple mutations of those genes are presented. Activation of both mutations does not necessarily pose a negative prediction.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

<a href="/en/project/NR9087" target="_blank" >NR9087: Use of molecular predictors for optimum selection of targeted therapy of non-small cell lung cancer</a><br>

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2010

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Anticancer Research

ISSN

0250-7005

e-ISSN

—

Volume of the periodical

30

Issue of the periodical within the volume

5

Country of publishing house

GR - GREECE

Number of pages

5

Pages from-to

—

UT code for WoS article

000279628200021

EID of the result in the Scopus database

—